Decreased Expression of Nuclear p300 Is Associated with Disease Progression and Worse Prognosis of Melanoma Patients

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Rotte, Anand ^a   Bhandaru, Madhuri ^a   Cheng, Yabin ^a   Sjoestroem, Cecilia ^a   Martinka, Magdalena ^a   Li, Gang ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE ACETYLTRANSFERASE PCAF;

ADULT; AGE; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL MIGRATION; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DYSPLASTIC NEVUS; FEMALE; GENDER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTATIC MELANOMA; PREDICTION; PRIMARY TUMOR; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TISSUE MICROARRAY;

CELL NUCLEUS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOMIC INSTABILITY; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MELANOMA; P300-CBP TRANSCRIPTION FACTORS; PROPORTIONAL HAZARDS MODELS; ROC CURVE; TISSUE ARRAY ANALYSIS;

EID: 84884797260     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075405     Document Type: Article

References (40)

1. Eckner R, Ewen ME, Newsome D, Gerdes M, DeCaprio JA, et al. (1994) Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev 8: 869-884.
2. Iyer NG, Ozdag H, Caldas C, (2004) p300/CBP and cancer. Oncogene 23: 4225-4231.
3. Roth SY, Denu JM, Allis CD, (2001) Histone acetyltransferases. Annu Rev Biochem 70: 81-120.
4. Reed SH, (2011) Nucleotide excision repair in chromatin: damage removal at the drop of a HAT. DNA Repair (Amst) 10: 734-742.
5. Price BD, D'Andrea AD, (2013) Chromatin remodeling at DNA double-strand breaks. Cell 152: 1344-1354.
6. Manuyakorn A, Paulus R, Farrell J, Dawson NA, Tze S, et al. (2010) Cellular histone modification patterns predict prognosis and treatment response in resectable pancreatic adenocarcinoma: results from RTOG 9704. J Clin Oncol 28: 1358-1365.
7. Fraga MF, Ballestar E, Villar-Garea A, Boix-Chornet M, Espada J, et al. (2005) Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet 37: 391-400.
8. Elsheikh SE, Green AR, Rakha EA, Powe DG, Ahmed RA, et al. (2009) Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome. Cancer Res 69: 3802-3809.
9. Peifer M, Fernandez-Cuesta L, Sos ML, George J, Seidel D, et al. (2012) Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat Genet 44: 1104-1110.
10. Pasqualucci L, Dominguez-Sola D, Chiarenza A, Fabbri G, Grunn A, et al. (2011) Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature 471: 189-195.
11. Le Gallo M, O'Hara AJ, Rudd ML, Urick ME, Hansen NF, et al. (2012) Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes. Nat Genet 44: 1310-1315.
12. Yokomizo C, Yamaguchi K, Itoh Y, Nishimura T, Umemura A, et al. (2011) High expression of p300 in HCC predicts shortened overall survival in association with enhanced epithelial mesenchymal transition of HCC cells. Cancer Lett 310: 140-147.
13. Li Y, Yang HX, Luo RZ, Zhang Y, Li M, et al. (2011) High expression of p300 has an unfavorable impact on survival in resectable esophageal squamous cell carcinoma. Ann Thorac Surg 91: 1531-1538.
14. Byers HR, Etoh T, Doherty JR, Sober AJ, Mihm MC Jr, (1991) Cell migration and actin organization in cultured human primary, recurrent cutaneous and metastatic melanoma. Time-lapse and image analysis. Am J Pathol 139: 423-435.
15. Chen G, Cheng Y, Zhang Z, Martinka M, Li G, (2011) Cytoplasmic Skp2 expression is increased in human melanoma and correlated with patient survival. PLoS One 6: e17578.
16. Zhang Z, Chen G, Cheng Y, Martinka M, Li G, (2011) Prognostic significance of RUNX3 expression in human melanoma. Cancer 117: 2719-2727.
17. Remmele W, Stegner HE, (1987) [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]. Pathologe 8: 138-140.
18. Zhang G, Li G, (2012) Novel multiple markers to distinguish melanoma from dysplastic nevi. PLoS One 7: e45037.
19. Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, et al. (2009) Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 27: 6199-6206.
20. Gonzaga ER, (2009) Role of UV light in photodamage, skin aging, and skin cancer: importance of photoprotection. Am J Clin Dermatol 10Suppl 1: 19-24.
21. Wang QE, Han C, Zhao R, Wani G, Zhu Q, et al. (2013) p38 MAPK- and Akt-mediated p300 phosphorylation regulates its degradation to facilitate nucleotide excision repair. Nucleic Acids Res 41: 1722-1733.
22. Tillhon M, Cazzalini O, Nardo T, Necchi D, Sommatis S, et al. (2012) p300/CBP acetyl transferases interact with and acetylate the nucleotide excision repair factor XPG. DNA Repair (Amst) 11: 844-852.
23. Bandyopadhyay D, Okan NA, Bales E, Nascimento L, Cole PA, et al. (2002) Down-regulation of p300/CBP histone acetyltransferase activates a senescence checkpoint in human melanocytes. Cancer Res 62: 6231-6239.
24. Kang J, Shi Y, Xiang B, Qu B, Su W, et al. (2005) A nuclear function of beta-arrestin1 in GPCR signaling: regulation of histone acetylation and gene transcription. Cell 123: 833-847.
25. Chen G, Cheng Y, Zhang Z, Martinka M, Li G, (2011) Prognostic significance of cytoplasmic p27 expression in human melanoma. Cancer Epidemiol Biomarkers Prev 20: 2212-2221.
26. Yan G, Eller MS, Elm C, Larocca CA, Ryu B, et al. (2013) Selective Inhibition of p300 HAT Blocks Cell Cycle Progression, Induces Cellular Senescence, and Inhibits the DNA Damage Response in Melanoma Cells. J Invest Dermatol.
27. Chen J, Li Q, (2011) Life and death of transcriptional co-activator p300. Epigenetics 6: 957-961.
28. Chen YJ, Wang YN, Chang WC, (2007) ERK2-mediated C-terminal serine phosphorylation of p300 is vital to the regulation of epidermal growth factor-induced keratin 16 gene expression. J Biol Chem 282: 27215-27228.
29. Yuan LW, Gambee JE, (2000) Phosphorylation of p300 at serine 89 by protein kinase C. J Biol Chem. 275: 40946-40951.
30. Bricambert J, Miranda J, Benhamed F, Girard J, Postic C, et al. (2010) Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice. J Clin Invest 120: 4316-4331.
31. Liu Y, Denlinger CE, Rundall BK, Smith PW, Jones DR, (2006) Suberoylanilide hydroxamic acid induces Akt-mediated phosphorylation of p300, which promotes acetylation and transcriptional activation of RelA/p65. J Biol Chem 281: 31359-31368.
32. Huang WC, Chen CC, (2005) Akt phosphorylation of p300 at Ser-1834 is essential for its histone acetyltransferase and transcriptional activity. Mol Cell Biol 25: 6592-6602.
33. Chen J, Halappanavar SS, St-Germain JR, Tsang BK, Li Q, (2004) Role of Akt/protein kinase B in the activity of transcriptional coactivator p300. Cell Mol Life Sci 61: 1675-1683.
34. Poizat C, Puri PL, Bai Y, Kedes L, (2005) Phosphorylation-dependent degradation of p300 by doxorubicin-activated p38 mitogen-activated protein kinase in cardiac cells. Mol Cell Biol 25: 2673-2687.
35. Abi-Habib RJ, Urieto JO, Liu S, Leppla SH, Duesbery NS, et al. (2005) BRAF status and mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 activity indicate sensitivity of melanoma cells to anthrax lethal toxin. Mol Cancer Ther 4: 1303-1310.
36. Pavey S, Johansson P, Packer L, Taylor J, Stark M, et al. (2004) Microarray expression profiling in melanoma reveals a BRAF mutation signature. Oncogene 23: 4060-4067.
37. Finn L, Markovic SN, Joseph RW, (2012) Therapy for metastatic melanoma: the past, present, and future. BMC Med 10: 23.
38. Giannini G, Cabri W, Fattorusso C, Rodriquez M, (2012) Histone deacetylase inhibitors in the treatment of cancer: overview and perspectives. Future Med Chem 4: 1439-1460.
39. Murakami T, Sato A, Chun NA, Hara M, Naito Y, et al. (2008) Transcriptional modulation using HDACi depsipeptide promotes immune cell-mediated tumor destruction of murine B16 melanoma. J Invest Dermatol 128: 1506-1516.
40. Landreville S, Agapova OA, Matatall KA, Kneass ZT, Onken MD, et al. (2012) Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma. Clin Cancer Res 18: 408-416.